Results 91 to 100 of about 207,765 (264)

Acute Cresentric IgA Nephritis in a Patient with Hodgkin’s Lymphoma

open access: yesTurkish Journal of Nephrology, 2019
In glomerular diseases, the occurence of lymphoma is mostly observed in the form of both minimal change disease and Hodgkin’s lymphoma. The coocurrence of Membranous nephropathy and membranoproliferative glomerulonephritis are generally associated with ...
Ebru GÖK OĞUZ   +5 more
doaj  

Classical Hodgkin’s Lymphoma Presenting as Acute Hepatic Failure—One Case Report

open access: yesCancer Biology & Medicine, 2010
A 20-year-old boy presenting daily febrile episodes was suspected to have developed acute hepatic failure. Serologic tests ruled out infectious and autoimmune causes apart from drug toxicity. During clinical examinations, he was found to have generalized
Sekhar Mukherjee   +3 more
doaj   +1 more source

Non-Hodgkin’s Lymphoma Mass Causing Superior Vena Cava Syndrome and Disappeared Completely with Low-dose Steroid: Case Report

open access: yes, 2020
Superior vena cava syndrome is a rare oncologic emergency in children. Non-Hodgkin’s lymphoma is the most common tumor and the most common subtype is T-cell non-Hodgkin’s lymphoma. Steroids, chemotherapy and radiotherapy are used for treatment.
Doğan Köse, Halil Aslan
core   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm   +2 more
wiley   +1 more source

Large cell lymphoma : correlation of HIV status and prognosis with differentiation profiles assessed by immunophenotyping [PDF]

open access: yes, 2011
Includes abstract.Includes bibliographical references (leaves 80-93).The study aimed to contribute a South African perspective by correlating the HIV status and prognosis of DLBCL and PBL with differentiation profiles assessed by ...
Pather, Sugeshnee
core   +1 more source

Determination of B-cell clonality in Hodgkin’s lymphoma

open access: yesКлиническая онкогематология, 2014
B-cell origin of Hodgkin’s lymphoma was demonstrated using microdissection and single cell PCR of Reed-Sternberg and Hodgkin cells (R. Kuppers et al., 1994).
Yu. V. Sidorova   +8 more
doaj   +1 more source

PERCUTANEOUS HISTOPATHOLOGIC EVALUATION OF LIVER IN TREATMENT OF NON-HODGKIN’S LYMPHOMA [PDF]

open access: yes, 1988
The results of 25 percutaneous biopsies of the liver from 24 patients with non-Hodgkin’s lymphoma are reported. In all cases, the value of their serum biochemistry (LDH, GOT, GPT and/or alkaline phosphatase) was abnormal and sufficient tissue material ...
Shunji, YOSHIMATSU
core   +1 more source

Model‐informed optimal dose selection of golcadomide in combination with R‐CHOP in patients with previously untreated aggressive B‐cell lymphoma

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Golcadomide is a potential first‐in‐class oral CELMoD™ agent for the treatment of lymphoma. This study aims to develop model‐informed drug development (MIDD) approaches to support optimal dose selection of golcadomide in combination with immunotherapy rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R‐CHOP) in alignment with ...
Xirong Zheng   +7 more
wiley   +1 more source

Development of multiple myeloma in a patient with chronic hepatitis C: A case report and review of the literature [PDF]

open access: yes, 2006
An association between chronic hepatitis C virus (HCV) infection and essential mixed cryoglobulinaemia and non-Hodgkin lymphoma (NHL) has been suggested. However, a causative role of HCV in these conditions has not been established.
Lakatos, Péter László   +4 more
core   +1 more source

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
External control (EC) arms using routine data can be used as comparators in clinical trials under certain conditions. The objective of this study was to assess the ability of an EC arm to replicate outcomes of a randomized controlled trial (RCT) arm receiving the same treatment strategy in advanced stage classical Hodgkin lymphoma and serve as ...
Olivia Febvey‐Combes   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy